For Media Professionals

Corporate Information

This information is intended for media professionals and investors

News Release

DFine Europe GmbH Accepts Terms of Preliminary Injuction Issued by German Court for Medtronic GmbH

DFine EUROPE GmbH to Stop Using Certain Promotional Claims about Its Bone Cement

MINNEAPOLIS – JUNE 26, 2009 – Medtronic, Inc. today announced that DFine Europe GmbH has accepted the terms of a preliminary injunction granted to Medtronic GmbH by a German Competition Court. The preliminary injunction stops DFine Europe GmbH from using certain misleading marketing claims related to Medtronic’s Kyphon® Balloon Kyphoplasty products in Germany.

On May 19, 2009, a German Competition Court issued a preliminary injunction for Medtronic GmbH against DFine Europe GmbH (District Court of Cologne, court file no. 33 0 147/09). With this preliminary injunction, DFine Europe GmbH was ordered to refrain from using certain promotional claims comparing its bone cement StabiliT™ ER2 to Medtronic’s  KyphX® HV-R™ Bone Cement (now known as KYPHON® HV-R® Bone Cement).

A preliminary injunction under German law provides the claimant with the option to ask a competition court to issue a preventive measure against assumed anti-competitive behavior, including illegal advertising. DFine Europe GmbH has accepted the terms of the preliminary injunction as binding.

ABOUT MEDTRONIC
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s Annual Report on Form 10-K for the year ended April 24, 2009. Actual results may differ materially from anticipated results.

Balloon kyphoplasty incorporates technology developed by Gary K. Michelson, M.D.

-end-